Literature DB >> 8581279

Adenosine receptor-mediated relaxation of guinea-pig precontracted, isolated trachea.

A Losinski1, S P Alexander.   

Abstract

1. We have investigated the pharmacological profile of the adenosine receptor mediating relaxation of the carbachol pre-contracted guinea-pig trachea. 2. 5'-N-Ethylcarboxamidoadenosine (NECA) and 2-chloroadenosine elicited concentration-dependent relaxations with pD2 (-log10 half-maximal values) of 6.37 +/- 0.04 and 5.25 +/- 0.09, with maximal relaxations of 73 +/- 7 and 208 +/- 38%, respectively. In the presence of 10 microM NECA, 2-chloroadenosine was able to relax the tissue further with a pD2 value of 4.74 +/- 0.11 and a maximal response of 252 +/- 68%. 3. CGS 21680, APEC and adenosine failed to elicit significant relaxations of precontracted tracheal rings at concentrations below 10 microM. At 10 microM, adenosine analogues elicited relaxations with the following order of magnitude (% relaxation): 2-chloroadenosine (75 +/- 16%) = NECA (69 +/- 16%) > APEC (25 +/- 8%) > CGS 21680 (11 +/- 2%) > adenosine (6 +/- 4%). 4. NECA-induced relaxation of precontracted trachea was antagonized by adenosine receptor antagonists with the rank order of apparent affinity (Ki, nM): PD 115,199 (27 +/- 8) = XAC (43 +/- 11) > CP 66,713(285 +/- 89) = DPCPX (316 +/- 114). 5. We conclude that the adenosine analogue-induced relaxation of guinea-pig tracheal rings fails to fit into the current classification of A2 adenosine receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8581279      PMCID: PMC1909068          DOI: 10.1111/j.1476-5381.1995.tb15090.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  17 in total

Review 1.  Cardiovascular purinoceptors.

Authors:  R A Olsson; J D Pearson
Journal:  Physiol Rev       Date:  1990-07       Impact factor: 37.312

Review 2.  Adenosine receptor subtypes.

Authors:  M G Collis; S M Hourani
Journal:  Trends Pharmacol Sci       Date:  1993-10       Impact factor: 14.819

Review 3.  Nomenclature and classification of purinoceptors.

Authors:  B B Fredholm; M P Abbracchio; G Burnstock; J W Daly; T K Harden; K A Jacobson; P Leff; M Williams
Journal:  Pharmacol Rev       Date:  1994-06       Impact factor: 25.468

4.  Cloning and expression of the A2a adenosine receptor from guinea pig brain.

Authors:  F Meng; G X Xie; D Chalmers; C Morgan; S J Watson; H Akil
Journal:  Neurochem Res       Date:  1994-05       Impact factor: 3.996

Review 5.  Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions.

Authors:  J Linden
Journal:  Trends Pharmacol Sci       Date:  1994-08       Impact factor: 14.819

6.  Evidence for an A2/Ra adenosine receptor in the guinea-pig trachea.

Authors:  C M Brown; M G Collis
Journal:  Br J Pharmacol       Date:  1982-07       Impact factor: 8.739

7.  Effects of the selective adenosine A2 receptor agonist CGS 21680 on in vitro electrophysiology, cAMP formation and dopamine release in rat hippocampus and striatum.

Authors:  C R Lupica; W A Cass; N R Zahniser; T V Dunwiddie
Journal:  J Pharmacol Exp Ther       Date:  1990-03       Impact factor: 4.030

8.  Adenosine receptor-induced second messenger production in adult guinea-pig cerebellum.

Authors:  F Hernández; D A Kendall; S P Alexander
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

9.  A comparison of A2 adenosine receptor-induced cyclic AMP generation in cerebral cortex and relaxation of pre-contracted aorta.

Authors:  S P Alexander; A Losinski; D A Kendall; S J Hill
Journal:  Br J Pharmacol       Date:  1994-01       Impact factor: 8.739

10.  A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.

Authors:  S P Alexander; A R Curtis; D A Kendall; S J Hill
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

View more
  1 in total

1.  Characterization of the human brain putative A2B adenosine receptor expressed in Chinese hamster ovary (CHO.A2B4) cells.

Authors:  S P Alexander; J Cooper; J Shine; S J Hill
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.